Page last updated: 2024-11-04

threo-alpha-methylisocitrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

threo-alpha-methylisocitrate: RN given refers to cpd without specific stereochemistry; designated cpd not in Chemline 11/1/79 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-hydroxybutane-1,2,3-tricarboxylic acid : A tricarboxylic acid that is butan-2-ol in which a hydrogen from each of positions 2, 3, and 4 has been replaced by carboxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID513
CHEBI ID142525
SCHEMBL ID321093
MeSH IDM0075516

Synonyms (18)

Synonym
3-hydroxy-1,2,3-butanetricarboxylate
8518ec1z2e ,
1,2,3-butanetricarboxylic acid, 3-hydroxy-
unii-8518ec1z2e
dl-threo-alpha-methylisocitrate
alpha-methylisocitrate
threo-alpha-methylisocitrate
d.l-methylisocitrate
6061-95-6
CHEBI:142525
3-hydroxybutane-1,2,3-tricarboxylic acid
3-carboxy-2,3-dideoxy-4-c-methylpentaric acid
SCHEMBL321093
(2r,3s)2-methylisocitrate
dl-methylisocitric acid
3-hydroxy-1,2,3-butanetricarboxylic acid
methyl isocitric acid
DTXSID20976051
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
methylisocitric acidA tricarboxylic acid that is isocitric acid substituted by a methyl group alpha- to one of the carboxylic acid groups.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.23 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]